BDTX
Price
$4.47
Change
-$0.40 (-8.21%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
277.18M
125 days until earnings call
Intraday BUY SELL Signals
RLAY
Price
$6.46
Change
+$0.28 (+4.54%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
1.07B
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDTX vs RLAY

Header iconBDTX vs RLAY Comparison
Open Charts BDTX vs RLAYBanner chart's image
Black Diamond Therapeutics
Price$4.47
Change-$0.40 (-8.21%)
Volume$19.18K
Capitalization277.18M
Relay Therapeutics
Price$6.46
Change+$0.28 (+4.54%)
Volume$18.88K
Capitalization1.07B
BDTX vs RLAY Comparison Chart in %
BDTX
Daily Signal:
Gain/Loss:
RLAY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BDTX vs. RLAY commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Buy and RLAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BDTX: $4.87 vs. RLAY: $6.17)
Brand notoriety: BDTX and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 151% vs. RLAY: 106%
Market capitalization -- BDTX: $277.18M vs. RLAY: $1.07B
BDTX [@Biotechnology] is valued at $277.18M. RLAY’s [@Biotechnology] market capitalization is $1.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 0 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • BDTX’s FA Score: 0 green, 5 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than BDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 4 TA indicator(s) are bullish while RLAY’s TA Score has 4 bullish TA indicator(s).

  • BDTX’s TA Score: 4 bullish, 4 bearish.
  • RLAY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BDTX and RLAY are a good buy in the short-term.

Price Growth

BDTX (@Biotechnology) experienced а +25.84% price change this week, while RLAY (@Biotechnology) price change was -5.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

BDTX is expected to report earnings on Mar 18, 2026.

RLAY is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($1.07B) has a higher market cap than BDTX($277M). BDTX YTD gains are higher at: 127.570 vs. RLAY (49.757). BDTX has higher annual earnings (EBITDA): 5.05M vs. RLAY (-338.15M). RLAY has more cash in the bank: 657M vs. BDTX (143M). BDTX has less debt than RLAY: BDTX (20.8M) vs RLAY (34.2M). BDTX has higher revenues than RLAY: BDTX (70M) vs RLAY (8.36M).
BDTXRLAYBDTX / RLAY
Capitalization277M1.07B26%
EBITDA5.05M-338.15M-1%
Gain YTD127.57049.757256%
P/E Ratio13.15N/A-
Revenue70M8.36M838%
Total Cash143M657M22%
Total Debt20.8M34.2M61%
TECHNICAL ANALYSIS
Technical Analysis
BDTXRLAY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 23 days ago
89%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signal:
Gain/Loss:
RLAY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSHUX30.350.27
+0.90%
Kinetics Spin-Off and Corp Rest Instl
HDVTX13.520.07
+0.52%
Hartford International Equity R5
DDZRX14.580.05
+0.34%
Macquarie Value R6
PLGJX11.16-0.01
-0.09%
Principal LargeCap Growth I J
TIHGX95.41-0.50
-0.52%
The Investment House Growth

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with RLAY. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
+5.41%
RLAY - BDTX
55%
Loosely correlated
-1.91%
NRIX - BDTX
49%
Loosely correlated
-5.37%
VYGR - BDTX
49%
Loosely correlated
-0.23%
CRBU - BDTX
48%
Loosely correlated
+0.89%
CGEM - BDTX
47%
Loosely correlated
+7.05%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with NRIX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-1.91%
NRIX - RLAY
55%
Loosely correlated
-5.37%
BDTX - RLAY
54%
Loosely correlated
+5.41%
IMNM - RLAY
53%
Loosely correlated
-0.51%
CRNX - RLAY
52%
Loosely correlated
-0.28%
IMTX - RLAY
52%
Loosely correlated
+16.10%
More